This was the stock's second consecutive day of losses.

New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing, information, and services. With a market ...

Analyst Eric Coldwell from Robert W. Baird reiterated a Hold rating on Quest Diagnostics (DGX – Research Report) and increased the price ...

The rising demand for prostate cancer diagnostics is mainly driven by the growing incidence of the disease, heightened awareness and screening initiatives, and ongoing advancements in diagnostic ...

DelveInsight's Prostate Cancer Diagnostics Market Insights report provides the current and forecast market analysis, ...

The company has a new logo, designed by Pentagram, that looks incredibly plain — especially compared to previous iterations of the logo that featured a rakish slant, two shades of blue ...

AB ANALITICA partners in DECIDER project to improve diagnostics and treatment of ovarian cancer with the help of AI – 15 mil­lion euros in fund­ing from the EU 3DHISTECH unveils its latest ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced acquisition of select laboratory assets from Allina Health.

(RTTNews) - Quest Diagnostics (DGX), a provider of diagnostic information services, announced that it has completed its acquisition of select laboratory assets from Allina Health. Financial ...

SECAUCUS, N.J., Sept. 16, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced ...

In this interview, discover how Charles River uses the power of microdialysis for drug development as well as CNS therapeutics. In this interview, we explore global and local efforts to combat ...